Tag: J

J&J Acquires Intra-Cellular Therapies for $14.6B, Expanding Mental Health Drug PortfolioIn a groundbreaking move that has sent shockwaves through the pharmaceutical industry, Johnson & Johnson announced on Monday that it would be acquiring Intra-Cellular...